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RESEARCH ARTICLE
Increased incidence of gonorrhoea and chlamydia in Greenland 1990–2012
Mila Broby Johansena, Anders Kocha, Jan Wohlfahrta, Mads Kamper-Jørgensenb, Steen Hoffmannc
and Bolette Soborga
aDepartment of Epidemiology Research, Statens Serum Institut, Copenhagen S, Denmark; bUniversity of Copenhagen, Department of Public
Health, Copenhagen K, Denmark; cDepartment of Microbiology and Infection Control, Statens Serum Institut, Copenhagen S, Denmark
ABSTRACT
Background: Since the 1970s, Greenland has presented the highest reported incidence rates of
the sexually transmitted infections (STIs) gonorrhoea and chlamydia in the Arctic regions.
Objective: This study aims to describe sex- and age-specific incidence rates of gonorrhoea and
chlamydia from 1990 to 2012 in Greenland, and to evaluate if changes in case definitions, diagnostic
procedures and implementation of STI interventions during the period coincide with rate changes.
Design: Gonorrhoea and chlamydia cases were identified from the national STI surveillance. For
1990–2008, STI cases were identified from weekly notified aggregated data. For 2009–2012, cases
were identified in person-identifiable national registers. We used log-linear Poisson regression to
calculate incidence rates (IRs) and incidence rate ratios (IRRs) with 95% confidence intervals (95% CI).
Analyses were stratified according to sex, age and calendar period.
Results: Gonorrhoea and chlamydia incidence rates have increased since 1995 to reach 2,555 per
100,000 person-years (PY) for gonorrhoea and 6,403 per 100,000 PY for chlamydia in 2012. From
2006 to 2012, the incidence rates among young adults aged 15–19 years were 8,187 and 22,515
per 100,000 PY for gonorrhoea and chlamydia, respectively. Changes in surveillance reporting did
not seem to influence the incidence rates for either disease, whereas a change in diagnostic test
coincided with an increased incidence of chlamydia.
Conclusion: Overall, the incidence of chlamydia in Greenland increased during the study period,
whereas the incidence of gonorrhoea decreased until 1995 but increased thereafter. Young
adults aged 15–24 years were at highest risk of infection. The increase in incidence rates was
independent of changes in case definitions, whereas an observed increase in chlamydia incidence
in 2005 coincided with a change in diagnostic test. None of the STI interventions launched after
1995 seemed to coincide with decreasing national incidence rates.
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Introduction
Although mortality from infectious diseases has
declined in Greenland since the 1950s, morbidity from
infectious diseases remains a prominent public health
issue, with sexually transmitted infections (STI) being of
particular concern. Since the 1970s, Greenland has pre-
sented the highest incidence rates of STI among Arctic
populations [1,2]. In 1975, the rate of gonorrhoea was
42,000 per 100,000 persons [2]. To reduce the high
incidence rates of gonorrhoea, the Greenlandic health
authorities launched focused efforts [3]. This resulted in
marked reductions in incidence rates, but the decrease
in rates of gonorrhoea did not continue after the 1990s.
Gesink et al. showed that the incidence rates of gonor-
rhoea and chlamydia increased in the North American
Arctic area population from 2003 to 2006, with the
highest rates observed in Greenland [4].
During the 1990s the Greenlandic health authorities
have initiated several new prevention and control mea-
sures in order to reduce STI incidence rates.
Introduction of new diagnostic methods, enhancement
of the existing STI surveillance system and the launch of
interventions such as information and screening cam-
paigns represent such initiatives set up according to the
World Health Organization’s (WHO) recommendations
[5]. However, no formal evaluation of the impact of
these initiatives has been conducted.
We carried out a population-based study to describe
sex- and age-specific incidence rates of gonorrhoea and
chlamydia from 1990 to 2012 in Greenland.
Furthermore, we wanted to evaluate whether changes
in surveillance methods, notification methods, diagnos-
tic methods, and implementation of STI intervention
campaigns coincided with changes in STI incidence
rates over the period.
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Material and methods
Setting
Greenland is an integral part of the Kingdom of
Denmark, but with self-rule. In 2015, Greenland had a
population of approximately 56,000 people [6]. The
majority (89%) of the Greenlandic population are Inuit
and the remaining part mostly Danes. Living conditions
are comparable with those of Inuit in Canada and
Alaskan Natives. Greenland provides universal and free
access to healthcare to all, including medicines. Health
care is provided by a local hospital in each of the 16
towns and 1 central hospital in the capital Nuuk.
Data sources
In Greenland, every citizen is given a unique person
identification number through the Civil Registration
System (CRS) that follows the person from birth to
death and uniquely identifies the person in national
registers. The CRS register provides information on
sex, date and place of birth, and continuously updated
place of residence.
STI notifications
In Greenland, cases of gonorrhoea, syphilis, chlamydia
and HIV are mandatory notifiable to the Chief Medical
Officer.
From 1990 to 2008, the cumulative numbers of cases
of gonorrhoea and chlamydia stratified by age and sex
were reported on a weekly basis from each health
district to the Chief Medical Officer of Greenland. Case
definitions for gonorrhoea and chlamydia were based
on clinical criteria or a combination of clinical criteria
and laboratory confirmation.
In 2009, the surveillance system changed to record
person-identifiable cases of STIs. Case definitions chan-
ged for both diseases to being purely laboratory based
on identification of the bacterial pathogens.
STI sampling
In Greenland, STI testing is performed in the following
situations:
(a) In case of symptoms, (b) prior to abortion, (c)
prior to prescribing contraceptives, (d) in case of STI
partner notifications, (e) if requested by the patient
because of risk behaviour.
Pregnant women are routinely screened for syphilis,
hepatitis B, HIV, Chlamydia trachomatis and Neisseria
gonorrhoeae [7]. When admitted for surgical proce-
dures, patients are routinely tested for HIV infection.
Diagnostic procedures
A diagnostic test for C. trachomatis first became avail-
able in 1994 in Nuuk and in the rest of Greenland in
1995. Until 2005, sample collection was based on cervi-
cal and urethral swabs sent to the central microbiolo-
gical laboratory in Nuuk, where an ELISA (enzyme-
linked immunosorbent assay) test was performed. In
2005, a NAAT (nucleic acid amplification test) based
on a strand displacement amplification assay (SDA)
replaced the ELISA test.
Until 2005, laboratory diagnosis of N. gonorrhoeae
was based on cervical and urethral swabs. The gold
standard method was microscopy after methylene
blue staining carried out at the place of sample collec-
tion. If a positive microscopy result was obtained, cul-
ture was done at the central laboratory in Nuuk. As for
chlamydia, in 2005 the diagnostic test changed to NAAT
carried out at the central laboratory in Nuuk.
In 2010 sampling changed from swabbing to urine
sampling for both pathogens at the majority of health
clinics in Greenland. Rectal or throat swabbing is very
seldom done (H.C.F. Sørensen, Personal communication,
Chief district officer of Tasiilaq, East Greenland, 2016).
Nationwide interventions
Interventions launched during the study period were
identified from the annual reports of the Greenlandic
Department of Health [8], publications from the
National Board of Health and Promotion (PAARISA) [9]
and from peer-reviewed articles [10]. Interventions prior
to 1992 were identified through peer-reviewed articles,
reports and personal communication.
Interventions carried out in Greenland during
1990–2012 were categorised into groups of targeted
interventions such as mass screening and case findings,
and primary prevention focusing on behavioural
changes. The Appendix outlines the intervention
classification.
Statistical analysis
Age-, sex- and period-specific incidence rates of gonor-
rhoea and chlamydia during 1990–2012 were estimated
as the sum of cases divided by the sum of person-years
(PY) at risk in strata of age, sex and period. For
1990–2008 the number of cases was obtained from
the weekly reported aggregated lists, whereas for
2009–2012 the number of cases was obtained from
the individual registrations in the STI surveillance sys-
tem. Duplicate positive samples from the same person
on the same day were excluded. From 1990 to 2008 PY
were approximated by population size from Statistics
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Greenland [11]. From 2009 and onwards PY were calcu-
lated from time of residence in Greenland since 1
January 2009, until 31 December 2012, death or emi-
gration, whichever came first. Incidence rate ratios
(IRRs) and 95% confidence intervals were estimated by
log-linear Poisson regression of age, sex and period-
specific number of cases with logarithm of PY at risk
as offset. Differences in incidence rates according to sex
and age were evaluated for 3 periods (1990–1995,
1996–2005, 2006–2012) using the middle period as
reference. Data was divided in the 3 periods according
to changes in diagnostic procedures. The middle period
was chosen as reference, as the later period is the most
relevant for present interventions and the prior period
represents features not relevant when comparing with
the latest period. The IRRs according to period by sex
and age were estimated by introducing interaction
terms in the regression.
To compensate for overdispersion due to dependent
events within (a person may present repeatedly with
STI) and between persons (STI in one person affects the
risk in other persons), variance was estimated by
moment estimator with a dispersion factor based on
Pearson statistics [12]. P-values were based on likeli-
hood ratio tests. Analyses were performed using the
GENMOD procedure in SAS 9.4.
Ethical considerations
The study complies with the Helsinki Declaration II. The
Commission for Scientific Research in Greenland
(approval No. 2013-X086740) and the Danish Data
Protection Agency approved the study (Journal No.
2008-54-0472).
Results
Incidence rates 1990–2012
For gonorrhoea, the incidence rate declined by 89%
from 1990 to 1995 with a rate of 4,444 per 100,000 PY
in 1990 to 511 per 100,000 PY in 1995 (Figure 1). From
1995 and onwards, incidence rates increased steadily to
reach 2,555 per 100,000 PY in 2012.
For chlamydia the incidence rate increased during
the whole study period. The most marked increase in
incidence was observed from 1994 to 1997, when the
incidence increased from 1,069 per 100,000 PY in 1994
to 3,257 per 100,000 PY in 1997 (Figure 1). From 1996 to
2004 the incidence was stable, while from 2004, yet
another increase was observed and the incidence
reached 6,403 per 100,000 PY in 2012.
As shown in Figure 1, the incidence rate of chlamy-
dia increased in 1995, coinciding with the implementa-
tion of a national diagnostic test procedure for
chlamydia, and increased sharply in 2005, coinciding
with a change to a more sensitive diagnostic NAAT
test. The change of surveillance system in 2009 did
not seem to coincide with a change in incidence rates,
as the rates began to increase before the change of
surveillance. The change of diagnostic sample proce-
dure from swabs to urine seemed to coincide with a
continuously increased incidence.
Tables 1 and 2 show incidence rates (IR) and IRR
stratified by calendar period, sex, and age.
The incidence rates of gonorrhoea varied signifi-
cantly by sex and age over the period (Table 1). Men
had the highest incidence rate during 1990–1995, and
women during 2006–2012. Overall the incidence rate
increased in all age groups from 1990–1995 to
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Figure 1. Incidence rates of gonorrhoea and chlamydia in Greenland 1990–2012 with concurrent diagnostic methods and marked
year of change (2009) in surveillance system from weekly reported aggregated number to individually notifiable infections.
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2006–2012, except for persons aged 30 years or older.
Persons aged 20–24 years had the highest incidence
rate of gonorrhoea during 1990–1995, while the inci-
dence rate was highest among the 15–19-year-olds
during 2006–2012. Although based on very few cases,
the incidence rate of gonorrhoea in the youngest age
group of 0–14 year olds decreased significantly from 95
per 100,000 PY during 1990–1995 to 54 per 100,000 PY
during 1996–2005, followed by a marked increase to
138 per 100,000 PY during 2006–2012. There was no
significant interaction between sex and age during the
3 periods; hence, the variation in incidence by age was
comparable for women and men between the periods.
For chlamydia the incidence rate was higher among
women than men over the entire period 1990–2012
(Table 2). While incidence rates increased for both men
and women throughout the period, the increase was
similar for men and women from 1990–1995 to
1996–2005, but significantly higher for men than
women from 1996–2005 to 2006–2012. The incidence
rates increased in all age groups, with the 15–19-year-
olds having the highest rates during the entire period.
Again, while based only on few cases in the youngest age
group (0–14 years) during 2006–2012, an increase in
incidence rates was observed from 1996–2005 to
2006–2012, significantly more pronounced for girls than
boys [IRR=1.72 (95% CI 1.35–2.19)]. In the same period a
decrease was observed for boys [IRR=0.71 (95% CI 0.35–
1.36)], although not significant. In contrast, a significant
increase from 1996–2005 to 2006–2012 was observed in
men aged 30 years or older [IRR=1.38 (95% CI 1.25–1.52)].
Discussion
This study presents an age-, sex-, and period-specific over-
view of nationwide incidence rates of gonorrhoea and
chlamydia in Greenland during 1990–2012. This is, to our
knowledge, themost comprehensive study on gonorrhoea
and chlamydia in Greenland based on nationwide figures,
and the first to evaluate changes in incidence rates and
their association with changes in surveillance activity, diag-
nostic methods, and initiation of campaign interventions.
Throughout the study period, the incidence rates of
gonorrhoea and chlamydia in Greenland were among the
highest in the world. In 2012, the figures from Greenland
were 213 and 14 times higher, respectively, than the
figures from Denmark (gonorrhoea [13]: 12/100,000; chla-
mydia [14]: 473/100,000), and comparable with national
Table 1. Nationwide incidence rates (IR) and incidence rate ratios (IRR) of gonorrhoea in Greenland 1990–2012.
1990–1995 1996–2005 2006–2012
IRa
per 100,000 PY
IRRb
(95% CI)
IRa
per 100,000 PY
IRR
(95% CI)
IRa
per 100,000 PY
IRRc
(95% CI)
Total 1,979 1,138 1,918
Sexd p-value=0.02 p-value=<0.0001
Women 1,777 1.38 (1.22–1.55) 1,133 1 (ref) 2,248 1.76 (1.64–1.89)
Men 2,159 1.66 (1.49–1.84) 1,143 1 (ref) 1,624 1.30 (1.21–1.39)
Age (years)e p-value=0.002 p-value=<0.0001
0–14 95 1.78 (0.88–3.63) 54 1 (ref) 138f 2.58 (1.70–3.98)
15–19 6,044 1.24 (1.05–1.46) 4,855 1 (ref) 8,187 1.68 (1.54–1.84)
20–24 7,223 1.50 (1.29–1.74) 4,807 1 (ref) 7,938 1.65 (1.50–1.81)
25–29 3,743 1.42 (1.19–1.71) 2,631 1 (ref) 4,096 1.55 (1.37–1.50)
30+ 1,112 1.95 (1.67–2.28) 570 1 (ref) 627 1.10 (0.99–1.23)
Sex and ageg p-value=0.75 p-value=0.19
Women 0–14 171 2.03 (1.16–3.56) 84 1 (ref) 262 3.10 (1.89–5.24)
15–19 7,106 1.15 (0.98–1.34) 6,193 1 (ref) 11,106 1.79 (1.59–2.03)
20–24 6,265 1.51 (1.28–1.79) 4,143 1 (ref) 8,273 2.00 (1.71–2.33)
25–29 2,875 1.36 (1.10–1.69) 2,110 1 (ref) 4,011 1.90 (1.53–2.37)
30+ 837 1.76 (1.46–2.12) 477 1 (ref) 567 1.19 (0.98–1.44)
Men 0–14 22 0.94 (0.23–3.28) 23 1 (ref) 19 0.82 (0.19–2.94)
15–19 5,067 1.41 (1.17–1.70) 3,587 1 (ref) 5,291 1.48 (1.25–1.74)
20–24 8,091 1.49 (1.30–1.72) 5,425 1 (ref) 7,615 1.40 (1.22–1.62)
25–29 4,510 1.46 (1.24–1.72) 3,089 1 (ref) 4,176 1.35 (1.12–1.63)
30+ 1,329 2.06 (1.80–2.37) 645 1 (ref) 677 1.05 (0.90–1.22)
IR, incidence rate; IRR, incidence rate ratio; CI, confidence interval.
a Incidence rate per 100,000 person-years (PY).
b p-values in the column for 1990–1995 represent tests comparing the age and sex specific IRRs for 1990–1995 versus 1996–2005, interaction between
covariates and period.
c p-values in the column for 2006–2012 represent tests comparing the age and sex specific IRRs for 2006–2012 versus 1996–2005, interaction between
covariates and period.
d Adjusted for age.
e Adjusted for sex.
f The percentage aged 13 and 14 years were 16 and 84%, respectively (based on individual registered cases in 2009–2012). In 1990–1995, 1996–2005 and
2006–2012, total events were 85, 81 and 127, respectively for persons aged 0–14 years.
g Adjusted for sex and age interaction.
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figures from Alaska [15] (gonorrhoea: 100/100,000, chla-
mydia: 749/100,000) and among high-risk female sex
workers in India [16] (gonorrhoea: 5,170/100,000, chlamy-
dia: 5,680/100,000).
The incidence rate of gonorrhoea was not consistent
throughout the study period, but steadily increased for
chlamydia. Gonorrhoea incidence decreased markedly
from 1990 to 1995, but increased thereafter, most pro-
nounced in the period 2006 to 2012. Yet, the incidence
rate by the end of the observational period in 2012 was
still lower than that observed in the beginning of the
period in 1990. The highest incidence rates for both
diseases throughout the study period were observed
among young adults aged 15–24 years.
Prior to 1995, chlamydia was infrequently diagnosed
due to lack of proper diagnostic methods nationally.
Yet, a number of factors may have influenced the inci-
dence rates of the 2 infections, including sex, age, surveil-
lance strategies, diagnostic procedures, and interventions.
Sex
A constantly higher incidence of both infections was
noted for women throughout the study period,
except for 1990–1995 when the gonorrhoea
incidence was higher among men. A plausible expla-
nation is the sensitivity and specificity of the diag-
nostic microscopy of urethral secretion used in
1990–1995, which is known to be much higher
among men with urethral symptoms than among
women [17]. Microscopy of the cervix, rectum and
throat has a low sensitivity and specificity [18,19].
Previous studies [3,20] have suggested that the high
incidence rate among men in Greenland was a con-
sequence of higher incidence among Danish immi-
grant workers, who tended to be male, single and
>30 years of age. However, a high incidence rate was
also observed among women in 1990–1995 com-
pared with 1996–2005, and is therefore not only
explained by the presence of Danish immigrant work-
ers. We speculate whether the high incidence among
women is an artefact due to the higher number
tested. Whether an increase in the incidence among
men would have been higher with the introduction
of rectal/pharyngeal testing is unknown.
Age
Throughout the entire period, both infections clearly
occurred at a higher frequency among persons aged
Table 2. Nationwide incidence rates (IR) and incidence rate ratios (IRR) of chlamydia in Greenland 1990–2012.
1990–1995 1996–2005 2006–2012
IRa
per 100,000 PY
IRRb
(95% CI)
IRa
per 100,000 PY
IRR
(95% CI)
IRa
per 100,000 PY
IRRc
(95% CI)
Total 687 3,455 5,077
Sexd p-value=0.69 p-value=0.03
Women 864 0.17 (0.15–0.19) 4,417 1 (ref) 6,378 1.28 (1.23–1.32)
Men 535 0.18 (0.16–0.20) 2,616 1 (ref) 3,920 1.36 (1.30–1.42)
Age (years)e p-value=<0.0001 p-value=<0.0001
0–14 38 0.16 (0.07–0.30) 240 1 (ref) 368f 1.53 (1.24–1.89)
15–19 2,955 0.17 (0.15–0.20) 17,056 1 (ref) 22,515 1.31 (1.25–1.38)
20–24 1,987 0.13 (0.11–0.15) 15,905 1 (ref) 21,241 1.33 (1.26–1.40)
25–29 1,348 0.18 (0.15–0.22) 7,341 1 (ref) 10,756 1.46 (1.35–1.57)
30+ 353 0.27 (0.22–1.32) 1,316 1 (ref) 1,513 1.15 (1.07–1.22)
Sex and ageg p-value=0.99 p-value=<0.0001
Women 0–14 64 0.16 (0.08–0.28) 401 1 (ref) 688 1.72 (1.35–2.19)
15–19 4,263 0.18 (0.15–0.20) 24,231 1 (ref) 31,718 1.31 (1.23–1.39)
20–24 2,312 0.13 (0.11–0.15) 17,966 1 (ref) 24,271 1.35 (1.25–1.45)
25–29 1,540 0.19 (0.15–0.22) 8,323 1 (ref) 11,380 1.37 (1.23–1.52)
30+ 416 0.27 (0.22–0.32) 1,561 1 (ref) 1,478 0.95 (0.85–1.05)
Men 0–14 13 0.16 (0.03–0.47) 85 1 (ref) 60 0.71 (0.35–1.36)
15–19 1,751 0.17 (0.14–0.21) 10,256 1 (ref) 13,386 1.31 (1.19–1.43)
20–24 1,693 0.12 (0.10–0.15) 13,986 1 (ref) 18,317 1.31 (1.21–1.42)
25–29 1,179 0.18 (0.15–0.22) 6,476 1 (ref) 10,173 1.57 (1.40–1.76)
30+ 302 0.27 (0.22–0.33) 1,117 1 (ref) 1,541 1.38 (1.25–1.52)
IR, incidence rate; IRR, incidence rate ratio; CI, confidence interval.
a Incidence rate per 100,000 person-years (PY).
b p-values in the column for 1990–1995 represent tests comparing the age and sex specific IRRs for 1990–1995 versus 1996–2005.
c p-values in the column for 2006–2012 represent tests comparing the age and sex specific IRRs for 2006–2012 versus 1996–2005.
d Adjusted for age.
e Adjusted for sex.
f The percentage aged 12, 13 and 14 years were 1.5, 7 and 90%, respectively (based on individual registered cases in 2009–2012). In 1990–1995, 1996–2005
and 2006–2012, total events were 34, 364 and 338, respectively for persons aged 0–14 years.
g Adjusted for sex and age interaction.
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15–24 years. This is not surprising and has been seen
before in Greenland [21]. However, we were surprised
that both gonorrhoea and chlamydia occurred in teenagers
aged 14 and younger. Despite the fact that only few events
of the 2 infections occurred in this age group, and primarily
among 13–14-year-olds and not younger persons, it was
worrying that the incidence in this age group increased
from 1996–2005 to 2006–2012. Previous studies [22,23]
report increased STI incidences to be associated with
early intercourse, risk-taking behaviour such as less con-
dom use, more lifetime partners and higher STI burden,
especially among young women. During the past 20 years,
the sexual debut of the majority of Greenlanders seems to
have remained at age 14 years [24,25], although 1 report
from 2010 showed earlier sexual debut (12–13-year-olds:
31% of girls, 14% of boys), with only around 50% having
used condoms [24]. The explanation for the early debut of
STIs may be multifactorial, including an early sexual debut
and more frequent use of testing among young teenagers.
As the incidence of STIs in young teenagers does not seem
to decrease with time, particular attention to this group
should be paid by the health system.
Surveillance strategies
In line with the WHO’s strategy on the prevention of
STIs [5] and the European Centre for Disease Prevention
and Control (ECDC) [26], Greenland changed surveil-
lance system in 2009 to a purely laboratory-based
reporting system with individually notifiable notifica-
tions. Elsewhere, this approach has resulted in better
coverage and more complete data on STIs [27]. There
was an increase from 2009; however, a constant
increase in incidence rates was already noted in the
years preceding. Thus, the change did not seem to
influence the incidence rates in Greenland. However,
although a case diagnosis prior to 2009 might not
always have been laboratory confirmed, laboratory test-
ing had been widely used, therefore making it difficult
to investigate the effect of the changes in 2009.
Diagnostic procedures
An increase in the incidence of chlamydia coincided
with the implementation of a diagnostic test for chla-
mydia in 1995, and again in 2005 after the introduction
of NAAT instead of an ELISA-based test. Although chla-
mydia ELISA testing was introduced on a national scale
in 1995, chlamydia incidence rates increased before
that. However, the test was introduced already in
1994 in Nuuk (25% of the total population of
Greenland). In addition to the fact that a number of
research studies were carried out prior to 1995 and that
screening efforts were carried out as part of the Stop-
AIDS campaign in 1992 [28], this may have contributed
to increased notification of chlamydia cases prior to
1995. An increase in chlamydia incidence with the intro-
duction of a NAAT test is consistent with findings from
the United Kingdom [29], where a 61% increase in
chlamydia incidence after the introduction of NAAT
was observed, explained by better coverage [30].
Change in diagnostic methods did not alone explain
the increase, as the incidence increased steadily after
2005. In contrast, no effect of the change to NAAT
testing was observed for gonorrhoea. The most likely
explanation is that the difference in sensitivity is lower
between conventional gonorrhoea diagnostics using
microscopy and NAAT testing than between the first
chlamydia test and NAAT [18]. Therefore NAAT has only
coincided with a slight increase in the observed inci-
dence of gonorrhoea. In 2010, urine sampling was
introduced instead of swabbing. Urine sampling is pre-
ferred to swabbing by patients because of less discom-
fort. Furthermore, it is less labour intensive, thus
allowing a larger number of persons to be tested,
including asymptomatic persons [31], and may have
contributed to the continuous increase after 2010.
However, with the introduction of self-obtained urine
sampling in Greenland, less partner notification takes
place and fewer partners are tested and treated. This
most likely leads to spread of infections.
Interventions
Except for a decrease in gonorrhoea incidence during
1990–1994 under the Stop-AIDS campaign, the inci-
dence rates of the 2 infections increased during the
study period in spite of contemporary intervention
campaigns. None of the intervention strategies since
1995 seemed to coincide with changes in incidence
rates for both infections. However, the increased aware-
ness of STI among patients could suggest a higher
degree of testing and thereby contribute to the
increase in incidences [32]. Still, it is unknown whether
the incidence rates would have been higher without
interventions. It was not possible to analyse effects of
individual interventions, as many were not structurally
evaluated and some were local and others national
interventions.
In the 1960s [33] and 1970s [34] mass screenings with
partner notifications and treatment guidelines according
to antimicrobial resistance patterns proved to be effec-
tive. The decrease in gonorrhoea incidence under the
Stop-AIDS campaign might be attributable to a multi-
pronged nationwide approach: continuously intensified
interventions from the 1980s onwards with both mass
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screenings, partner notifications, focus on sexual beha-
viour and information about STI, as well as preventive
work with employment of a venereologist setting up
venereal clinics and updating treatment guidelines.
Since the Stop-AIDS campaign there have been no nation-
wide multi-pronged campaigns in Greenland. The inter-
ventions have mainly been based on behavioural change
and local community interventions [10,35]. Low et al.
emphasise a multi-pronged approach in order to combat
STI burdens to target risk factors both on the individual,
partnership and population level [32]. A multi-pronged
approach is suggested to be effective in order to reach as
many of the sexually active persons in different age
groups, social and cultural levels as possible. Rink et al.
and Homøe et al. also suggest that education may be
effective in reducing STI incidences [10,35] and should
be considered included in a multi-pronged approach.
Strengths and limitations
The main strength of this study is the use of national
surveillance and central laboratory data, which ensures
completeness of STI cases in the population from 1990 to
2012. A limitation is that counting of cases during
1990–2008 was based on aggregated anonymised data.
Thus, double registration cannot be excluded for this
period. However, as registration was focused on persons
rather than tests, we believe that only a limited number
of double registrations occurred. During 2009–2012 all
duplicate registrations of the same person with the same
date and same disease were excluded, thus minimising
the problem with double registrations of same episode.
Possible double registrations within 3 weeks for gonor-
rhoea and 4 weeks for chlamydia were few, namely 1.5%
and 2%, respectively. Obviously, some STI episodes may
not have been diagnosed or reported. Differences in
testing frequency between towns and settlements may
be due to the difference in health care centres between
towns and settlements (hospitals in towns and nurse
stations in settlements). However, the high rates suggest
an overall high attention and frequent health-seeking
behaviour related to STIs in Greenland in the period. We
therefore believe that underreporting does not play a
major role in Greenland.
Conclusion
Overall, the incidence of chlamydia in Greenland
increased during the study period, whereas the incidence
of gonorrhoea decreased until 1995 as part of a historical
trend since 1970s but increased thereafter. Young adults
aged 15–24 years were at highest risk of infection.
Although cases were few, incidence rates among the
13–14-year-olds increased in particular. None of the STI
interventions launched after 1995 seemed to coincide
with decreasing national incidence rates. The introduction
of a more sensitive diagnostic test method coincided with
an increase in the incidence rate of chlamydia in 2005.
Continued multi-pronged nationwide public health
efforts are warranted in order to combat STI in Greenland.
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